These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 24837877)
1. Population pharmacokinetic analysis of digoxin in Chinese neonates and infants. Gong Y; Chen Y; Li Q; Li Z J Pharmacol Sci; 2014; 125(2):142-9. PubMed ID: 24837877 [TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic investigation of digoxin in Japanese infants and young children. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M J Clin Pharmacol; 2011 Jun; 51(6):857-63. PubMed ID: 20592416 [TBL] [Abstract][Full Text] [Related]
3. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis. Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585 [TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic investigation of digoxin in Japanese neonates. Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of digoxin in elderly patients. Chen R; Zou SL; Wang ML; Jiang Y; Xue H; Qian CY; Xia ZL Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):115-21. PubMed ID: 23096939 [TBL] [Abstract][Full Text] [Related]
6. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense? el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model. Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062 [TBL] [Abstract][Full Text] [Related]
8. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients. Choi SA; Yun HY; Lee ES; Shin WG Clin Ther; 2014 Mar; 36(3):389-400. PubMed ID: 24612944 [TBL] [Abstract][Full Text] [Related]
9. Population analysis for the optimization of digoxin treatment in Japanese paediatric patients. Suematsu F; Minemoto M; Yukawa E; Higuchi S J Clin Pharm Ther; 1999 Jun; 24(3):203-8. PubMed ID: 10438180 [TBL] [Abstract][Full Text] [Related]
10. Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency. Du P; Wang A; Ma Y; Jia A; Li Y; Li X Clin Ther; 2020 Sep; 42(9):1799-1810.e3. PubMed ID: 32798059 [TBL] [Abstract][Full Text] [Related]
11. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization. EL Desoky ES; Nagaraja NV; Derendorf H Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice. Zhou XD; Gao Y; Guan Z; Li ZD; Li J Acta Pharmacol Sin; 2010 Jun; 31(6):753-8. PubMed ID: 20523346 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of digoxin in pediatric patients. Martín-Suárez A; Falcao AC; Outeda M; Hernández FJ; González MC; Quero M; Arranz I; Lanao JM Ther Drug Monit; 2002 Dec; 24(6):742-5. PubMed ID: 12451291 [TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics of Digoxin in Nonagenarian Patients: Optimization of the Dosing Regimen. Salcedo-Mingoarranz AL; Medellín-Garibay SE; Barcia-Hernández E; García-Díaz B Clin Pharmacokinet; 2023 Dec; 62(12):1725-1738. PubMed ID: 37816957 [TBL] [Abstract][Full Text] [Related]
16. The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure. Carlton LD; Patterson JH; Mattson CN; Schmith VD J Clin Pharmacol; 1996 Mar; 36(3):247-56. PubMed ID: 8690819 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population. Abdel Jalil MH; Abdullah N; Alsous MM; Saleh M; Abu-Hammour K Br J Clin Pharmacol; 2020 Jul; 86(7):1267-1280. PubMed ID: 32153059 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M J Clin Pharm Ther; 2011 Dec; 36(6):704-10. PubMed ID: 22023343 [TBL] [Abstract][Full Text] [Related]
19. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update. Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants. Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]